Pharmaceutical

Cesca Therapeutics (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that it has entered into an evaluation agreement with the University of North Carolina Lineberger Advanced Cellular Therapeutics Facility (ACT) to assess Cesca’s patented and proprietary X-Series products for automated, closed system cellular processing. As quoted in the …

Cesca Therapeutics (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that it has entered into an evaluation agreement with the University of North Carolina Lineberger Advanced Cellular Therapeutics Facility (ACT) to assess Cesca’s patented and proprietary X-Series products for automated, closed system cellular processing.

As quoted in the press release:

X-Series products are part of Cesca’s CAR-TXpress™ platform, which is an automated system that selects target cells using its patented, buoyancy-activated cell separation (X-BACS™) technology. The system is a multi-device platform designed to automate many of the manual steps currently involved in cell processing. As such, the CAR-TXpress system can provide a comprehensive and commercially viable, automated cellular manufacturing and control (CMC) solution for the development of CAR-T as well as CAR-NK therapeutics.

“As a pioneer in the research and development of novel CAR-T based therapeutics, we are delighted that ACT has selected our X-Series products for this important evaluation,” said Phil Coelho, chief technology officer of ThermoGenesis, Cesca’s device subsidiary. “The complexity of the CAR-T manufacturing process stands as a significant obstacle to the more rapid uptake of these ground-breaking therapies, contributing to lengthy treatment times and high costs. We believe CAR-TXpress can automate key steps in the process while at the same time improving cell yields and consistency. We are hopeful that this evaluation will lead to a long and productive collaboration with ACT.”

Click here to read the full press release.

MARKETS

Markets
TSX19692.92+236.21
TSXV646.04+10.63
DOW32798.40-46.73
S&P 5004118.63-11.66
NASD12368.98-21.71
ASX6993.00+47.80

COMMODITIES

Commodities
Gold1774.37+2.44
Silver20.30-0.03
Copper3.50-0.05
Palladium2172.54-24.46
Platinum910.89+0.90
Oil93.33-0.56
Heating Oil3.35-0.09
Natural Gas8.02-0.26

DOWNLOAD FREE REPORTS

×